EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Immune responsiveness in stable kidney transplantation patients: Complete inhibition of T‐cell proliferation but residual T‐cell activity during maintenance immunosuppressive treatment

Aliede E In 't Veld iD, Boukje C Eveleens Maarse iD, Maria J Juachon, Soufian Meziyerh iD, Aiko P J de Vries iD, Aline L van Rijn iD, Mariet C W Feltkamp iD, Dirk Jan A R Moes iD, Jacobus Burggraaf iD, Matthijs Moerland iD

Clinical and Translational Science · 2024

DOI: 10.1111/cts.13860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2024. Verfasst von Aliede E In 't Veld und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Human Drug Research, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Kidney Transplantation, Immunosuppressive Agents, T-Lymphocytes, Cell Proliferation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Foundation Centre for Human Drug Research (CHDR), Centre for Human Drug Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recommended immunosuppressive treatment after kidney transplantation consists of tacrolimus, mycophenolate mofetil, and low‐dose corticosteroids. Drug concentrations are monitored using therapeutic drug monitoring (TDM), which does not necessarily correlate with pharmacodynamic activity. To find the balance between optimal efficacy and minimal toxicity, it might be more informative to monitor patients' immunological status rather than drug concentrations. We selected a panel of T‐cell‐based immune assays, which were used for immunomonitoring of 14 stable kidney transplantation patients. Whole blood was incubated with a T‐cell stimulus, after which T‐cell proliferation, T‐cell activation marker expression and cytokine production were measured to study residual immune activity in vitro (before drug intake; drug added to the incubation) and ex vivo (after drug intake). T‐cell proliferation was completely suppressed in all patients over the full day, while IL‐2, IFN‐γ, CD71, and CD154 showed fluctuations over the day with a strong inhibition (75%–25%) at 2 h post‐dose. The level of inhibition was variable between patients and could not be related to pharmacokinetic parameters or the presence of regulatory or senescence immune cells. Moreover, the level of inhibition did not correlate with the in vitro tacrolimus drug effect as studied by incubating pre‐dose blood samples with additional tacrolimus. Overall, IL‐2, IFN‐γ, CD71, and CD154 seem to be good markers to monitor residual immune activity of transplantation patients. To evaluate the correlation between these pharmacodynamic biomarkers and clinical outcome, prospective observational studies are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationImmunosuppressive AgentsT-LymphocytesCell ProliferationTacrolimusLymphocyte ActivationDrug MonitoringHumansMaleMiddle AgedFemaleAdultAgedMycophenolic AcidInterferon-gamma

Substanzen

Immunosuppressive AgentsTacrolimusMycophenolic AcidInterferon-gamma

Autor:innen und Institutionen

  • Centre for Human Drug Research, Leiden, The Netherlands.
  • Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Division of Nephrology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Pharmacy and Clinical Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Leiden Academic Centre of Drug Research, Leiden University, Leiden, The Netherlands.

ORCID-Profile: Aliede E In 't Veld, Boukje C Eveleens Maarse, Soufian Meziyerh, Aiko P J de Vries, Aline L van Rijn, Mariet C W Feltkamp, Dirk Jan A R Moes, Jacobus Burggraaf, Matthijs Moerland

Förderung

  • Foundation Centre for Human Drug Research (CHDR)
  • Centre for Human Drug Research

Zitieren

APA

In 't Veld, A. E., Eveleens Maarse, B. C., Juachon, M. J., Meziyerh, S., de Vries, A. P. J., van Rijn, A. L., Feltkamp, M. C. W., Moes, D. J. A. R., Burggraaf, J., & Moerland, M. (2024). Immune responsiveness in stable kidney transplantation patients: Complete inhibition of T‐cell proliferation but residual T‐cell activity during maintenance immunosuppressive treatment. Clinical and Translational Science. https://doi.org/10.1111/cts.13860

Vancouver

In 't Veld AE, Eveleens Maarse BC, Juachon MJ, Meziyerh S, de Vries APJ, van Rijn AL, et al. Immune responsiveness in stable kidney transplantation patients: Complete inhibition of T‐cell proliferation but residual T‐cell activity during maintenance immunosuppressive treatment. Clinical and Translational Science. 2024. doi:10.1111/cts.13860

BibTeX
@article{IntVeld2024,
  author = {In 't Veld, Aliede E and Eveleens Maarse, Boukje C and Juachon, Maria J and Meziyerh, Soufian and de Vries, Aiko P J and van Rijn, Aline L and Feltkamp, Mariet C W and Moes, Dirk Jan A R and Burggraaf, Jacobus and Moerland, Matthijs},
  title = {Immune responsiveness in stable kidney transplantation patients: Complete inhibition of T‐cell proliferation but residual T‐cell activity during maintenance immunosuppressive treatment},
  journal = {Clinical and Translational Science},
  year = {2024},
  doi = {10.1111/cts.13860}
}
Kostenlos starten →